Seeing Is Believing
ANIP is currently covered by 4 analysts with an average price target of $94.66. This is a potential upside of $20.76 (28.09%) from yesterday's end of day stock price of $73.9.
ANI Pharmaceuticals's activity chart (see below) currently has 99 price targets and 78 ratings on display. The stock rating distribution of ANIP is 26.67% HOLD and 73.33% BUY.
Analysts average stock forecasts to be materialized ratio is 95.58% with an average time for these price targets to be met of 457.33 days.
Highest price target for ANIP is $124, Lowest price target is $90, average price target is $107.25.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 16-Jan-2026. First documented stock forecast 15-Dec-2014.
Currently out of the existing stock ratings of ANIP, 4 are a HOLD (26.67%), 11 are a BUY (73.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2023
$124
$50.1 (67.79%)
$115
1 months 13 days ago
(16-Jan-2026)
10/13 (76.92%)
$39.17 (46.17%)
291
Hold Since 11-Sep-2024
$90
$16.1 (21.79%)
$77
4 months 20 days ago
(09-Oct-2025)
13/13 (100%)
$-0.78 (-0.86%)
298
Buy Since 10-Jul-2025
$121
$47.1 (63.73%)
$93
5 months 12 days ago
(17-Sep-2025)
5/6 (83.33%)
$25.64 (26.89%)
540
Buy Since 07-Sep-2022
$94
$20.1 (27.20%)
$94
11 months 12 days ago
(17-Mar-2025)
13/13 (100%)
$29.65 (46.08%)
317
Buy Since 28-Feb-2019
$83
$9.1 (12.31%)
$49
1 years 5 months 11 days ago
(18-Sep-2024)
12/12 (100%)
$21.95 (35.95%)
597
What is ANIP (ANI Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ANIP (ANI Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ANIP (ANI Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ANIP (ANI Pharmaceuticals)?
Which analyst is the currently most bullish on ANIP (ANI Pharmaceuticals)?
Which analyst is the currently most reserved on ANIP (ANI Pharmaceuticals)?